Development of a hypoxia activated prodrug for the selective inhibition of DNA-dependent protein kinase
The presence of tumour hypoxia, regions of low levels of oxygen, is a distinct and exploitable feature of the solid tumour microenvironment. While its presence is generally accepted as a negative prognostic indicator, hypoxia is a relatively unique feature to solid tumours and can therefore be explo...
Main Author: | Cran, Jordan Darice |
---|---|
Language: | English |
Published: |
University of British Columbia
2013
|
Online Access: | http://hdl.handle.net/2429/44337 |
Similar Items
-
Development of a hypoxia activated prodrug for the selective inhibition of DNA-dependent protein kinase
by: Cran, Jordan Darice
Published: (2013) -
Development of a hypoxia activated prodrug for the selective inhibition of DNA-dependent protein kinase
by: Cran, Jordan Darice
Published: (2013) -
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
by: Yue Li, et al.
Published: (2021-07-01) -
Novel hypoxia-selective prodrugs of radiosensitisers and chemosensitisers
by: Parveen, Ifat
Published: (2001) -
Hypoxia-activated prodrugs and redox-responsive nanocarriers
by: Zeng Y, et al.
Published: (2018-10-01)